Članki z zahtevami za javni dostop - Thomas F PattersonVeč o tem
Ni na voljo nikjer: 1
Polymeric Iron Chelator with Enhanced Iron Affinity as a Broad-Spectrum Antifungal Agent
J Qian, NP Wiederhold, T Patterson, H Patterson, CJ Berkland
ACS Applied Polymer Materials 3 (12), 6034-6039, 2021
Zahteve: US National Institutes of Health
Na voljo nekje: 102
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
Zahteve: US Department of Defense, US National Institutes of Health, US Department of …
Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clinical infectious diseases 46 (12), 1813-1821, 2008
Zahteve: US National Institutes of Health
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical infectious diseases 63 (4), e1-e60, 2016
Zahteve: US National Institutes of Health, UK Medical Research Council, National …
Remdesivir for the treatment of Covid-19—preliminary report
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1836, 2020
Zahteve: US National Institutes of Health, UK Medical Research Council
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
Zahteve: UK Medical Research Council
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
Zahteve: US Department of Defense, US National Institutes of Health, US Department of …
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ...
The Lancet Infectious Diseases 21 (6), e149-e162, 2021
Zahteve: US Department of Defense, Canadian Institutes of Health Research, Fonds de …
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ...
Jama 329 (22), 1934-1946, 2023
Zahteve: US National Institutes of Health
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of …
BH Segal, R Herbrecht, DA Stevens, L Ostrosky-Zeichner, J Sobel, ...
Clinical infectious diseases 47 (5), 674-683, 2008
Zahteve: US National Institutes of Health
Factors associated with mortality in transplant patients with invasive aspergillosis
JW Baddley, DR Andes, KA Marr, DP Kontoyiannis, BD Alexander, ...
Clinical Infectious Diseases 50 (12), 1559-1567, 2010
Zahteve: US National Institutes of Health
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the …
M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ...
The Lancet Infectious Diseases 21 (8), e246-e257, 2021
Zahteve: US National Institutes of Health, German Research Foundation, UK Medical …
Oropharyngeal candidiasis in the era of antiretroviral therapy
GR Thompson III, PK Patel, WR Kirkpatrick, SD Westbrook, D Berg, ...
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2010
Zahteve: US National Institutes of Health
Strain-Dependent Variation in 18S Ribosomal DNA Copy Numbers in Aspergillus fumigatus
ML Herrera, AC Vallor, JA Gelfond, TF Patterson, BL Wickes
Journal of clinical microbiology 47 (5), 1325-1332, 2009
Zahteve: US National Institutes of Health
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
GR Thompson III, NP Wiederhold, AC Vallor, NC Villareal, JS Lewis, ...
Antimicrobial agents and chemotherapy 52 (10), 3783-3785, 2008
Zahteve: US National Institutes of Health
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial
AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ...
The lancet respiratory medicine 9 (12), 1365-1376, 2021
Zahteve: US Department of Defense, US National Institutes of Health, US Department of …
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
PE Verweij, RJM Brüggemann, E Azoulay, M Bassetti, S Blot, JB Buil, ...
Intensive care medicine 47 (8), 819-834, 2021
Zahteve: US National Institutes of Health
Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
GR Thompson III, NP Wiederhold, AW Fothergill, AC Vallor, BL Wickes, ...
Antimicrobial Agents and Chemotherapy 53 (1), 309-311, 2009
Zahteve: US National Institutes of Health
Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids
V Mor, A Rella, AM Farnoud, A Singh, M Munshi, A Bryan, S Naseem, ...
MBio 6 (3), 10.1128/mbio. 00647-15, 2015
Zahteve: US National Institutes of Health, Wellcome Trust
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis
DP Kontoyiannis, V Ratanatharathorn, JA Young, J Raymond, ...
Transplant Infectious Disease 11 (1), 89-93, 2009
Zahteve: US National Institutes of Health
Podatke o objavi in financiranju samodejno določi računalniški program